GSK CEO Walmsley to Join Microsoft Board as Tech Giant Wades Deeper into Healthcare

GlaxoSmithKline CEO Emma Walmsley could soon have a new title: Microsoft board member. And it would be an appointment that’s potentially valuable for both companies’ endeavors into each other’s sectors...
Login to comment.